Literature DB >> 27423658

Dilated perivascular spaces and fatigue: is there a link? Magnetic resonance retrospective 3Tesla study.

Renata Conforti1, Mario Cirillo1, Angela Sardaro2, Giuseppina Caiazzo3, Alberto Negro1, Antonella Paccone3, Rosaria Sacco4, Maddalena Sparaco4, Antonio Gallo4, Luigi Lavorgna4, Gioacchino Tedeschi4, Sossio Cirillo1.   

Abstract

INTRODUCTION: Fatigue (F) is a common, inexplicable, and disabling symptom in multiple sclerosis (MS) patients. The purpose of this study was to evaluate a possible correlation between fatigue and morpho-volumetric features and site of dilated perivascular spaces (dPS), visible on 3T magnetic resonance (MR) in fatigued multiple sclerosis patients (FMS).
METHODS: We studied 82 relapsing remitting (RR) FMS patients and 43 HC, matched for age, sex, and education. F was assessed by the Fatigue Severity Scale (FSS). To evaluate a possible correlation between degree of F and characteristics of dPS, patients were divided in two groups: more (mFMS) (FSS ≥ 5; n = 30) and less fatigued (lFMS) (FSS ≥ 4; n = 52), compared to a matched healthy control (HC) subject group. The MR study was performed with 3T scanner by SpinEcho T1, Fast-SpinEcho DP-T2, FLAIR, and 3D FSPGR T1 sequences. dPS volumes were measured with Medical Image Processing Analysis and Visualization (MIPAV); Global Cerebral Atrophy (GCA), expressed as Brain Parenchymal Fraction (BPF), was assessed by FSL SIENAX.
RESULTS: The t test showed significantly increased dPS number (p = 0.021) in FMS patients (mFMS p = 0.0024 and lFMS p = 0.033) compared to HC. Pearson correlation revealed a significant correlation between dPS number and FSS (r = 0.208 p = 0.051). Furthermore, the chi-squared test confirms the intragroup (HC, mFMS, lFMS) differences about dPS location (p = 0.01) and size (p = 0.0001).
CONCLUSION: Our study confirms that PS in MS patients presents with different volumetric and site characteristics as compared to HC; moreover, F severity significantly correlates with dPS number, site, and size.

Entities:  

Keywords:  Dilated Virchow-Robin spaces (dVRS); Dilated perivascular spaces (dPS); Fatigue (F); Multiple sclerosis (MS)

Mesh:

Year:  2016        PMID: 27423658     DOI: 10.1007/s00234-016-1711-0

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  30 in total

1.  Early cellular events in multiple sclerosis. Intimations of an extrinsic myelinolytic antigen.

Authors:  Frederick W Gay
Journal:  Clin Neurol Neurosurg       Date:  2005-12-20       Impact factor: 1.876

Review 2.  Fatigue in multiple sclerosis - a brief review.

Authors:  Isuru Induruwa; Cris S Constantinescu; Bruno Gran
Journal:  J Neurol Sci       Date:  2012-08-27       Impact factor: 3.181

Review 3.  MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.

Authors:  Massimo Filippi; Maria Assunta Rocca
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

4.  Large Virchow-Robin spaces: MR-clinical correlation.

Authors:  L A Heier; C J Bauer; L Schwartz; R D Zimmerman; S Morgello; M D Deck
Journal:  AJNR Am J Neuroradiol       Date:  1989 Sep-Oct       Impact factor: 3.825

Review 5.  Fatigue in multiple sclerosis.

Authors:  L B Krupp; C Christodoulou
Journal:  Curr Neurol Neurosci Rep       Date:  2001-05       Impact factor: 5.081

6.  Enlarged perivascular spaces are associated with cognitive function in healthy elderly men.

Authors:  A M J Maclullich; J M Wardlaw; K J Ferguson; J M Starr; J R Seckl; I J Deary
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

Review 7.  Physiopathology of fatigue in multiple sclerosis.

Authors:  Letizia Leocani; Bruno Colombo; Giancarlo Comi
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

8.  Are multiple sclerosis and amyotrophic lateral sclerosis autoimmune disorders of endogenous vasoactive neuropeptides?

Authors:  Donald R Staines
Journal:  Med Hypotheses       Date:  2007-06-19       Impact factor: 1.538

9.  Deep gray matter and fatigue in MS: a T1 relaxation time study.

Authors:  G Niepel; Ch R Tench; P S Morgan; N Evangelou; D P Auer; C S Constantinescu
Journal:  J Neurol       Date:  2006-03-13       Impact factor: 4.849

10.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

View more
  4 in total

1.  Lesion Volume in Relapsing Multiple Sclerosis is Associated with Perivascular Space Enlargement at the Level of the Basal Ganglia.

Authors:  S C Kolbe; L M Garcia; N Yu; F M Boonstra; M Clough; B Sinclair; O White; A van der Walt; H Butzkueven; J Fielding; M Law
Journal:  AJNR Am J Neuroradiol       Date:  2022-02       Impact factor: 3.825

2.  Dilated Virchow-Robin space and Parkinson's disease: A case report of combined MRI and diffusion tensor imaging.

Authors:  Renata Conforti; Angela Sardaro; Alberto Negro; Giuseppina Caiazzo; Antonella Paccone; Rosita De Micco; Sossio Cirillo; Alessandro Tessitore
Journal:  Radiol Case Rep       Date:  2018-06-30

3.  Enlarged perivascular spaces in multiple sclerosis on magnetic resonance imaging: a systematic review and meta-analysis.

Authors:  Tobias Granberg; Thomas Moridi; Judith S Brand; Susanne Neumann; Martin Hlavica; Fredrik Piehl; Benjamin V Ineichen
Journal:  J Neurol       Date:  2020-06-13       Impact factor: 4.849

4.  Normal-sized basal ganglia perivascular space related to motor phenotype in Parkinson freezers.

Authors:  Wen Lv; Yumei Yue; Ting Shen; Xingyue Hu; Lili Chen; Fei Xie; Wenying Zhang; Baorong Zhang; Yaxing Gui; Hsin-Yi Lai; Fang Ba
Journal:  Aging (Albany NY)       Date:  2021-07-27       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.